Chemoinformaics analysis of (+)-Dihydrocuscohygrine
| Molecular Weight | 226.364 | nRot | 4 |
| Heavy Atom Molecular Weight | 200.156 | nRig | 10 |
| Exact Molecular Weight | 226.205 | nRing | 2 |
| Solubility: LogS | -0.875 | nHRing | 2 |
| Solubility: LogP | 0.634 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 42.0486 |
| nHD | 1 | BPOL | 29.5034 |
| QED | 0.783 |
| Synth | 3.46 |
| Natural Product Likeliness | 0.357 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.011 |
| Pgp-sub | 0.305 |
| HIA | 0.438 |
| CACO-2 | -4.856 |
| MDCK | 0.00000652 |
| BBB | 0.673 |
| PPB | 0.248422 |
| VDSS | 1.084 |
| FU | 0.804711 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.1 |
| CYP2c19-inh | 0.009 |
| CYP2c19-sub | 0.974 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.037 |
| CYP2d6-inh | 0.088 |
| CYP2d6-sub | 0.909 |
| CYP3a4-inh | 0 |
| CYP3a4-sub | 0.518 |
| CL | 11.55 |
| T12 | 0.503 |
| hERG | 0.132 |
| Ames | 0.008 |
| ROA | 0.092 |
| SkinSen | 0.916 |
| Carcinogencity | 0.233 |
| EI | 0.091 |
| Respiratory | 0.938 |
| NR-Aromatase | 0.002 |
| Antiviral | Yes |
| Prediction | 0.8137 |